{"id":"prothrombin-complex","safety":{"commonSideEffects":[{"rate":null,"effect":"Thromboembolism"},{"rate":null,"effect":"Allergic reaction"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":{"setId":"68fa4f90-8b01-6498-4140-e0be5247c3fe","title":"BALFAXAR (PROTHROMBIN COMPLEX CONCENTRATE (HUMAN)) POWDER, FOR SOLUTION [OCTAPHARMA USA INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Prothrombin complex is a pooled plasma-derived product containing the vitamin K-dependent factors II, VII, IX, and X. It rapidly restores these factors in patients with deficiency due to warfarin overdose, liver disease, or other causes, thereby correcting the prolonged prothrombin time (PT/INR) and restoring hemostatic capacity.","oneSentence":"Prothrombin complex concentrate replaces deficient vitamin K-dependent clotting factors (II, VII, IX, X) to restore coagulation cascade function.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:37.897Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Warfarin overdose or vitamin K deficiency with bleeding"},{"name":"Urgent reversal of warfarin anticoagulation"},{"name":"Coagulation factor deficiency due to liver disease or disseminated intravascular coagulation"}]},"trialDetails":[{"nctId":"NCT06883240","phase":"","title":"An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-04-29","conditions":"Von Willebrand Disease, Type 3","enrollment":40},{"nctId":"NCT05889494","phase":"NA","title":"Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2025-03-24","conditions":"Postoperative Hemorrhage, Postoperative Anemia, Postoperative Blood Loss","enrollment":64},{"nctId":"NCT07094087","phase":"PHASE3","title":"Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)","status":"RECRUITING","sponsor":"CSL Behring","startDate":"2025-09-15","conditions":"Complex Cardiovascular Surgery With Cardiopulmonary Bypass","enrollment":200},{"nctId":"NCT04563520","phase":"PHASE3","title":"SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"Hemophilia A","enrollment":5},{"nctId":"NCT07406139","phase":"PHASE4","title":"PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Hemophilia, Inhibitors","enrollment":30},{"nctId":"NCT06386107","phase":"NA","title":"Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2025-09-02","conditions":"Cancer, Pulmonary Embolism, Thrombosis","enrollment":212},{"nctId":"NCT06429332","phase":"PHASE4","title":"International Care Bundle Evaluation in Cerebral Hemorrhage Research","status":"RECRUITING","sponsor":"Region Skane","startDate":"2025-01-07","conditions":"Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage","enrollment":3500},{"nctId":"NCT07333144","phase":"","title":"Management of Gastrointestinal Bleeding Under Direct Oral Anticoagulants","status":"RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2025-02-28","conditions":"Gastrointestinal Bleeding","enrollment":250},{"nctId":"NCT07290634","phase":"","title":"Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion","status":"RECRUITING","sponsor":"Zeliha Alicikus","startDate":"2026-01-30","conditions":"Thromboembolus, Massive Blood Transfusion; Thrombocytopenia, Trauma","enrollment":4},{"nctId":"NCT02352181","phase":"NA","title":"Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-12","conditions":"Liver Transplantation","enrollment":82},{"nctId":"NCT05568888","phase":"PHASE3","title":"Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )","status":"TERMINATED","sponsor":"CSL Behring","startDate":"2023-03-28","conditions":"Traumatic Injury","enrollment":1366},{"nctId":"NCT04421924","phase":"NA","title":"Periinterventional Coagulation Management of Patients Undergoing a TIPS","status":"RECRUITING","sponsor":"Medical University of Graz","startDate":"2020-05-27","conditions":"Liver Cirrhosis","enrollment":39},{"nctId":"NCT04867837","phase":"PHASE3","title":"Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor","status":"RECRUITING","sponsor":"Octapharma","startDate":"2021-09-01","conditions":"Acute Major Bleeding","enrollment":260},{"nctId":"NCT04244981","phase":"PHASE4","title":"Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery","status":"RECRUITING","sponsor":"SHI Jia","startDate":"2023-10-25","conditions":"Cardiac Surgical Procedures","enrollment":820},{"nctId":"NCT04023019","phase":"","title":"Treatment of Hemophilia A Patients With FVIII Inhibitors","status":"RECRUITING","sponsor":"Emory University","startDate":"2020-03-17","conditions":"Hemophilia A","enrollment":120},{"nctId":"NCT05523297","phase":"PHASE3","title":"Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery","status":"COMPLETED","sponsor":"Octapharma","startDate":"2022-11-30","conditions":"Bleeding Cardiac Surgery Patients","enrollment":420},{"nctId":"NCT04543383","phase":"PHASE1","title":"A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-07-27","conditions":"Healthy","enrollment":52},{"nctId":"NCT07098676","phase":"","title":"Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Ai Peng","startDate":"2024-11-20","conditions":"Healthy Individuals (Controls), Vascular Surgery Patients With Acute Thrombosis, Dialysis Patients","enrollment":900},{"nctId":"NCT06144112","phase":"PHASE4","title":"Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery","status":"NOT_YET_RECRUITING","sponsor":"Konkuk University Medical Center","startDate":"2025-09-01","conditions":"Liver Diseases","enrollment":92},{"nctId":"NCT03598907","phase":"","title":"Point-of-care Management of Coagulopathy in Lung Transplantation","status":"TERMINATED","sponsor":"University Hospital, Motol","startDate":"2018-01-01","conditions":"Lung Transplantation","enrollment":100},{"nctId":"NCT06429787","phase":"","title":"Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure","status":"RECRUITING","sponsor":"Octapharma","startDate":"2025-02-14","conditions":"Vitamin K-Dependent Coagulation Defect, Significant Bleeding Risk","enrollment":3574},{"nctId":"NCT03341156","phase":"PHASE3","title":"Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2018-07-11","conditions":"Heart Disease End Stage, Heart Failure，Congestive","enrollment":14},{"nctId":"NCT03428711","phase":"PHASE2","title":"Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis","status":"COMPLETED","sponsor":"Quovadis Associazione","startDate":"2018-03-26","conditions":"Superficial Venous Thrombosis of Leg, Secondary Prevention","enrollment":560},{"nctId":"NCT02561923","phase":"PHASE1","title":"A Study to Assess the Independent Effects of 4-Factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding/Pharmacodynamics in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Scientific Affairs, LLC","startDate":"2015-08-27","conditions":"Healthy","enrollment":158},{"nctId":"NCT05281718","phase":"EARLY_PHASE1","title":"Factor IX as Adjunctive Therapy to Emicizumab (EMIX)","status":"COMPLETED","sponsor":"Tulane University","startDate":"2022-08-01","conditions":"Hemophilia A","enrollment":12},{"nctId":"NCT05667805","phase":"PHASE4","title":"Coagulation in Cirrhosis","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2023-01-19","conditions":"Liver Cirrhosis","enrollment":400},{"nctId":"NCT06635707","phase":"","title":"Efficacy and Safety Study of Urapidil Alone or With Esmolol in Treating Acute Hypertensive Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2024-11-01","conditions":"Hypertensive Intracerebral Hemorrhage","enrollment":600},{"nctId":"NCT06627218","phase":"NA","title":"Liberal or Adhere to Recommendations for PCC Management in Major Bleeding Following Trauma","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-01-01","conditions":"Traumatic Bleeding","enrollment":650},{"nctId":"NCT06565364","phase":"","title":"Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2019-01-07","conditions":"Thrombocytopenia, Antibodies Drug Specific","enrollment":160},{"nctId":"NCT02777424","phase":"PHASE4","title":"CPP Versus PFC to Correct Coagulation Disorders in Adult Neurosurgical Patients","status":"COMPLETED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2016-01-21","conditions":"Intracranial Hemorrhages","enrollment":18},{"nctId":"NCT06379126","phase":"","title":"The Diagnostic and Prognostic Value of TAT, PIC, tPAI·C and TM in Sepsis-induced Coagulopathy","status":"NOT_YET_RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2024-04-20","conditions":"Sepsis-induced Coagulopathy","enrollment":210},{"nctId":"NCT05205863","phase":"PHASE1, PHASE2","title":"Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation","status":"COMPLETED","sponsor":"Prothya Biosolutions","startDate":"2021-11-12","conditions":"Healthy Volunteers","enrollment":69},{"nctId":"NCT06144099","phase":"PHASE4","title":"Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery","status":"UNKNOWN","sponsor":"Konkuk University Medical Center","startDate":"2024-03-01","conditions":"Prostate Cancer, Spine, Open, Hip Osteoarthritis","enrollment":154},{"nctId":"NCT04019015","phase":"PHASE2","title":"Prehospital Kcentra for Hemorrhagic Shock","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2021-03-15","conditions":"Trauma Injury","enrollment":166},{"nctId":"NCT05548777","phase":"","title":"Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major Bleed","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-09-15","conditions":"Anticoagulant-related Major Bleed","enrollment":5480},{"nctId":"NCT06144125","phase":"PHASE4","title":"Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery","status":"UNKNOWN","sponsor":"Konkuk University Medical Center","startDate":"2024-03-01","conditions":"Cardiac Valve Disease","enrollment":152},{"nctId":"NCT03702582","phase":"PHASE3","title":"Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-04-30","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":100},{"nctId":"NCT03064035","phase":"PHASE4","title":"Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2017-04-05","conditions":"Acute Bleeding on Long-Term Anticoagulation Therapy, Hemorrhage, Significant Bleeding in Patients With a Coagulopathy (Prolonged Thrombin Time)","enrollment":79},{"nctId":"NCT02740335","phase":"PHASE3","title":"Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.","status":"COMPLETED","sponsor":"Octapharma","startDate":"2017-06-08","conditions":"Significant Bleeding Risk","enrollment":208},{"nctId":"NCT05738642","phase":"NA","title":"Evaluation of the Efficacy of Early Bunching of a FF-PCC in Patients With Severe Traumatic Hemorrhage","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-01","conditions":"Trauma","enrollment":380},{"nctId":"NCT02764489","phase":"PHASE3","title":"FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2019-02-12","conditions":"Hemophilia A or B With Inhibitors","enrollment":45},{"nctId":"NCT00618098","phase":"PHASE3","title":"Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures","status":"COMPLETED","sponsor":"Octapharma","startDate":"2008-05","conditions":"Reversal of Anticoagulant Treatment","enrollment":200},{"nctId":"NCT04534751","phase":"PHASE4","title":"Factor In the Initial Resuscitation of Severe Trauma 2 Patients","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2021-04-01","conditions":"Traumatic Hemorrhage, Coagulopathy, Massive Hemorrhage","enrollment":350},{"nctId":"NCT05020483","phase":"PHASE2","title":"FEIBA to Optimize Postcardiopulmonary Bypass Hemostasis in Pediatric Cardiac Patients","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2021-10","conditions":"Cardiac Disease","enrollment":""},{"nctId":"NCT03209258","phase":"NA","title":"The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial","status":"COMPLETED","sponsor":"The George Institute for Global Health, China","startDate":"2017-12-12","conditions":"Cerebral Hemorrhage, Stroke, Hypertension","enrollment":7067},{"nctId":"NCT03218722","phase":"PHASE3","title":"Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2017-12-29","conditions":"Shock, Hemorrhagic","enrollment":350},{"nctId":"NCT02433210","phase":"NA","title":"A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2015-06","conditions":"End Stage Renal Disease (ESRD)","enrollment":11},{"nctId":"NCT02557672","phase":"PHASE4","title":"PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-08","conditions":"Bleeding, Blood Loss, Surgical, Cardiovascular Surgical Procedures","enrollment":106},{"nctId":"NCT03417245","phase":"PHASE3","title":"A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2018-03-01","conditions":"Hemophilia A, Hemophilia B","enrollment":120},{"nctId":"NCT04434001","phase":"PHASE2","title":"ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery","status":"TERMINATED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2020-02-27","conditions":"Bleeding, Cardiac Defect, Surgery--Complications","enrollment":40},{"nctId":"NCT03320603","phase":"NA","title":"Use of Prothrombin Complex Concentrate in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants","status":"COMPLETED","sponsor":"Octapharma","startDate":"2017-10-13","conditions":"Emergency Care for Severe Bleeding While on Anticoagulants","enrollment":397},{"nctId":"NCT03784794","phase":"NA","title":"Patient Blood Management for Massive Obstetric Hemorrhage","status":"COMPLETED","sponsor":"Angel Augusto Perez Calatayud","startDate":"2018-11-01","conditions":"Post Partum Hemorrhage, Fibrinogenolysis; Hemorrhage, Fibrinogen; Deficiency, Acquired","enrollment":100},{"nctId":"NCT02319460","phase":"","title":"An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2014-04-24","conditions":"Hemorrhage","enrollment":2238},{"nctId":"NCT01159210","phase":"PHASE4","title":"Efficacy and Safety of Prothromplex Total (Prothrombin Complex Concentrate) in Oral Anticoagulant Reversal","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2010-07-09","conditions":"Prothrombin Complex Factor Deficiency","enrollment":61},{"nctId":"NCT03473132","phase":"PHASE4","title":"Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2018-03-15","conditions":"Anticoagulation, Anticoagulation Reversal","enrollment":50},{"nctId":"NCT01961804","phase":"PHASE3","title":"PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma","status":"TERMINATED","sponsor":"University Hospital, Angers","startDate":"2014-03","conditions":"Coagulation; Intravascular, Craniocerebral Trauma, Haemorrhage","enrollment":202},{"nctId":"NCT01128881","phase":"PHASE4","title":"IMMUNINE Pre-Treatment Study","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2010-05-31","conditions":"Hemophilia B","enrollment":57},{"nctId":"NCT03782025","phase":"","title":"Effect of Vitamin K in Critically Ill Patients","status":"COMPLETED","sponsor":"Region Skane","startDate":"2019-02-13","conditions":"Coagulation Factor Deficiency, Coagulopathy, Consumption, Vitamin K Deficiency","enrollment":52},{"nctId":"NCT03715348","phase":"PHASE2","title":"Trial of PCC Versus FFP in Patients Undergoing Heart Surgery","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2019-03-01","conditions":"Bleeding, Surgery, Transfusion","enrollment":50},{"nctId":"NCT04582188","phase":"","title":"The Early Coagulopathy for the Prognosis in Sepsis","status":"UNKNOWN","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2020-11-05","conditions":"Sepsis, Coagulopathy, Outcome, Fatal","enrollment":200},{"nctId":"NCT04114643","phase":"PHASE2","title":"Factor Replacement in Surgery","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2019-09-24","conditions":"Bleeding in Cardiac Surgery","enrollment":103},{"nctId":"NCT04614090","phase":"","title":"Fast Reversal of Warfarin and Early Surgery in Patients With Trochanteric Hip Fracture A Case-control Study","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2017-10-01","conditions":"Trochanteric Hip Fractures, Warfarin Medication, Early Surgery","enrollment":198},{"nctId":"NCT00221195","phase":"PHASE2, PHASE3","title":"Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors","status":"COMPLETED","sponsor":"Tulane University School of Medicine","startDate":"2003-06","conditions":"Hemophilia A With Inhibitors","enrollment":34},{"nctId":"NCT02461251","phase":"NA","title":"Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2016-01","conditions":"Obstetric Labor Complications, Hemorrhage","enrollment":59},{"nctId":"NCT03981484","phase":"PHASE2","title":"REPlaCE- Randomized Trial Evaluating the Use of Prothrombin Complex concEntrate to Improve Survival in Patients With Traumatic Coagulopathy","status":"UNKNOWN","sponsor":"Bellal A. Joseph, MD, FACS","startDate":"2020-01","conditions":"Coagulopathy, Hemorrhage","enrollment":280},{"nctId":"NCT02610153","phase":"","title":"Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-10-01","conditions":"Atrial Fibrillation","enrollment":1013},{"nctId":"NCT03287999","phase":"","title":"Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B","status":"UNKNOWN","sponsor":"Royal Free Hospital NHS Foundation Trust","startDate":"2017-09-19","conditions":"Haemophilia","enrollment":250},{"nctId":"NCT03080207","phase":"NA","title":"Platelet Rich Plasma, Complex Decongestive Physiotherapy and Low Level Laser in Treatment of Lower Extremity Lymphoedema","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2017-01-17","conditions":"Lower Extremity Lymphedema","enrollment":45},{"nctId":"NCT02047565","phase":"PHASE1","title":"A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2013-10","conditions":"Bleeding","enrollment":110},{"nctId":"NCT01910675","phase":"PHASE4","title":"PCC and Fibrinogen Compared With FFP in PPH","status":"WITHDRAWN","sponsor":"Helsinki University Central Hospital","startDate":"2013-07","conditions":"Postpartum Haemorrhage","enrollment":""},{"nctId":"NCT02565836","phase":"","title":"Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major Bleed","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2015-10","conditions":"Hemorrhage","enrollment":342},{"nctId":"NCT01053169","phase":"","title":"Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2010-05","conditions":"Coagulation Protein Disorders, Blood Loss, Surgical, Perioperative Care","enrollment":445},{"nctId":"NCT02949206","phase":"PHASE1","title":"A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Male Subjects","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-11-14","conditions":"Healthy","enrollment":80},{"nctId":"NCT03269019","phase":"","title":"Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia","status":"UNKNOWN","sponsor":"Wuhan Asia Heart Hospital","startDate":"2017-11-20","conditions":"Heparin-Induced Thrombocytopenia, Thrombosis, Biomarkers","enrollment":200},{"nctId":"NCT03034850","phase":"","title":"Thrombin Generation and Platelet Activation in CRS/HIPEC","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2015-04","conditions":"Mesothelioma; Peritoneum, Pseudomyxoma Peritonei, Peritoneal Carcinomatosis","enrollment":27},{"nctId":"NCT01656330","phase":"PHASE1","title":"A Study to Assess the Effects of 2 Different Prothrombin Complex Concentrates on the Pharmacodynamics of Rivaroxaban in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2012-07","conditions":"Healthy","enrollment":35},{"nctId":"NCT01779921","phase":"","title":"Treatment of Congenital Factor VII Deficiency","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-10","conditions":"Congenital Bleeding Disorder, Congenital FVII Deficiency","enrollment":163},{"nctId":"NCT02429453","phase":"NA","title":"FFP Versus PCC in Intracranial Hemorrhage","status":"WITHDRAWN","sponsor":"University of Utah","startDate":"2015-04","conditions":"Intracranial Hemorrhage, Traumatic, Intracranial Hemorrhage, Spontaneous","enrollment":""},{"nctId":"NCT02416817","phase":"PHASE4","title":"Strategy of Transfusion in Trauma Patients - STATA Trial","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2014-07","conditions":"Wounds and Injuries","enrollment":156},{"nctId":"NCT00928915","phase":"PHASE4","title":"International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage","status":"COMPLETED","sponsor":"Heidelberg University","startDate":"2009-07","conditions":"Intracranial Hemorrhages","enrollment":54},{"nctId":"NCT00842621","phase":"","title":"Long Term Effects of Erythrocyte Lysis","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2009-03","conditions":"Sickle Cell Disease, Hemolytic Anemia","enrollment":390},{"nctId":"NCT02270918","phase":"PHASE1","title":"Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2014-11","conditions":"Thrombosis","enrollment":12},{"nctId":"NCT02463591","phase":"PHASE2","title":"Reversal of Dabigatran With Prothrombin Complex Concentrate","status":"UNKNOWN","sponsor":"University Medical Center Groningen","startDate":"2015-01","conditions":"Drug Action Reversal","enrollment":12},{"nctId":"NCT02281201","phase":"PHASE3","title":"Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2014-10","conditions":"Acute Major Bleeding, Reversal of Coagulopathy","enrollment":11},{"nctId":"NCT01545635","phase":"PHASE3","title":"RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma","status":"TERMINATED","sponsor":"Medical University Innsbruck","startDate":"2012-03","conditions":"Major Trauma","enrollment":100},{"nctId":"NCT01382862","phase":"PHASE2","title":"PHANTOM-S: The Pre-Hospital Acute Neurological Therapy and Optimization of Medical Care in Stroke Patients - Study","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2011-05","conditions":"Acute Stroke","enrollment":614},{"nctId":"NCT02074358","phase":"PHASE1","title":"A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2014-02","conditions":"Anticoagulation","enrollment":43},{"nctId":"NCT00803101","phase":"PHASE3","title":"An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2009-02","conditions":"Reversal of Coagulopathy","enrollment":176},{"nctId":"NCT01471730","phase":"PHASE3","title":"The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery","status":"COMPLETED","sponsor":"IRCCS Policlinico S. Donato","startDate":"2011-11","conditions":"Heart Disease","enrollment":119},{"nctId":"NCT00708435","phase":"PHASE3","title":"Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2008-06","conditions":"Blood Coagulation Disorders, Acute Major Bleeding","enrollment":216},{"nctId":"NCT01352143","phase":"","title":"Thrombin Generation in Neonatal Plasma After Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Emory University","startDate":"2011-03","conditions":"Cardiopulmonary Bypass","enrollment":24},{"nctId":"NCT01269138","phase":"","title":"Treatment of Inherited Factor VII Deficiency","status":"COMPLETED","sponsor":"University of L'Aquila","startDate":"2007-01","conditions":"Factor VII Deficiency","enrollment":223},{"nctId":"NCT01670474","phase":"PHASE4","title":"Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA","status":"UNKNOWN","sponsor":"Centre Hospitalier du Centre du Valais","startDate":"2011-01","conditions":"Malfunction; Catheter, Thrombosis, Mechanical Complication of Hemodialysis Catheter","enrollment":240},{"nctId":"NCT00284193","phase":"PHASE4","title":"Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2005-01","conditions":"Hemophilia A","enrollment":5},{"nctId":"NCT01187030","phase":"","title":"Appropriateness of Frozen Plasma Use in Canada","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2008-05","conditions":"Blood Component Transfusion","enrollment":2580},{"nctId":"NCT00770718","phase":"PHASE1","title":"Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage","status":"TERMINATED","sponsor":"University of Utah","startDate":"2008-04","conditions":"Intracranial Hemorrhage","enrollment":2},{"nctId":"NCT00168077","phase":"PHASE3","title":"Prothrombin Complex Concentrate for Anticoagulant Reversal","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2005-09","conditions":"Acquired Coagulation Factor Deficiency","enrollment":40}],"_emaApprovals":[],"_faersSignals":[{"count":58,"reaction":"OFF LABEL USE"},{"count":39,"reaction":"DRUG INEFFECTIVE"},{"count":36,"reaction":"PRODUCT USE IN UNAPPROVED INDICATION"},{"count":34,"reaction":"NO ADVERSE EVENT"},{"count":26,"reaction":"DEEP VEIN THROMBOSIS"},{"count":25,"reaction":"ISCHAEMIC STROKE"},{"count":24,"reaction":"HAEMORRHAGE"},{"count":23,"reaction":"EMBOLISM"},{"count":22,"reaction":"PULMONARY EMBOLISM"},{"count":14,"reaction":"ACUTE KIDNEY INJURY"}],"_approvalHistory":[],"publicationCount":3039,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CONFIDEX"],"phase":"marketed","status":"active","brandName":"Prothrombin complex","genericName":"Prothrombin complex","companyName":"IRCCS Policlinico S. Donato","companyId":"irccs-policlinico-s-donato","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Prothrombin complex concentrate replaces deficient vitamin K-dependent clotting factors (II, VII, IX, X) to restore coagulation cascade function. Used for Warfarin overdose or vitamin K deficiency with bleeding, Urgent reversal of warfarin anticoagulation, Coagulation factor deficiency due to liver disease or disseminated intravascular coagulation.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}